HomeGLAXO • NSE
add
GlaxoSmithKline Pharmaceuticals Limited
Nakaraang pagsara
₹2,393.65
Sakop ng araw
₹2,361.60 - ₹2,413.40
Sakop ng taon
₹1,616.90 - ₹3,088.00
Market cap
394.59B INR
Average na Volume
95.78K
P/E ratio
60.21
Dividend yield
1.34%
Primary exchange
NSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 10.11B | 5.62% |
Gastos sa pagpapatakbo | 3.21B | -2.94% |
Net na kita | 2.52B | 16.09% |
Net profit margin | 24.98 | 9.90% |
Kita sa bawat share | — | — |
EBITDA | 3.21B | 11.39% |
Aktuwal na % ng binabayarang buwis | 26.56% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 21.11B | 31.49% |
Kabuuang asset | 37.46B | 14.55% |
Kabuuang sagutin | 20.73B | 19.80% |
Kabuuang equity | 16.73B | — |
Natitirang share | 172.12M | — |
Presyo para makapag-book | 24.63 | — |
Return on assets | — | — |
Return on capital | 43.75% | — |
Cash Flow
Net change in cash
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 2.52B | 16.09% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
Itinatag
Nob 13, 1924
Website
Mga Empleyado
3,211
